Stay updated with breaking news from Laura Hack. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A new study out of Stanford Medicine has found a "new category of depression" that impacts 27% of of diagnosed individuals and is "not effectively" treated by standard antidepressants.
A new category of depression, the cognitive biotype, accounts for 27% of depressed patients, say researchers.
Using surveys, cognitive tests and brain imaging, researchers have identified a type of depression that affects about a quarter of patients. The goal is to diagnose and treat the condition more precisely.
Scientists at Stanford Medicine conducted a study describing a new category of depression -; labeled the cognitive biotype -; which accounts for 27% of depressed patients and is not effectively treated by commonly prescribed antidepressants.
Researchers discovered a new depression subtype, the 'cognitive biotype,' affecting 27% of patients who respond poorly to typically prescribed antidepressants.